Table 1.
The clinical characteristics of the colorectal cancer (CRC) patients included in this study.
| Characteristics (n = 1792) | GEO-CRC (n = 1255) | TCGA-CRC (n = 537) | |||
|---|---|---|---|---|---|
| GSE39582 (n = 585) | GSE161158 (n = 250) | GSE14333 (n = 290) | GSE37892 (n = 130) | ||
| Age | |||||
| ≤ 65 | 228 (39.00%) | 126 (50.40%) | 133 (45.86%) | 55 (42.31%) | 234 (43.58%) |
| > 65 | 357 (61.00%) | 124 (49.60%) | 157 (54.14%) | 75 (57.69%) | 303 (56.42%) |
| Gender | |||||
| Male | 322 (55.04%) | – | 164 (56.55%) | 69 (53.08%) | 287 (53.45%) |
| Female | 263 (44.96%) | – | 126 (43.45%) | 61 (46.92%) | 250 (46.55%) |
| T Stage | |||||
| T1 | 16 (2.73%) | – | – | – | 15 (2.94%) |
| T2 | 49 (8.38%) | – | – | – | 93 (17.32%) |
| T3 | 379 (64.79%) | – | – | – | 366 (68.16%) |
| T4 | 119 (20.34%) | – | – | – | 63 (11.73%) |
| Unknown | 22 (3.76%) | ||||
| N Stage | |||||
| N0 | 314 (53.67%) | – | – | – | 316 (58.85%) |
| N1 | 106 (18.12%) | – | – | – | 128 (23.84%) |
| N2 | 137 (23.42%) | – | – | – | 92 (17.13%) |
| Unknown | 28 (4.79) | – | – | – | 1 (0.19%) |
| M Stage | |||||
| M0 | 499 (85.30%) | – | – | – | 400 (74.49%) |
| M1 | 61 (10.43%) | – | – | – | 75 (13.97%) |
| Unknown | 25 (4.27%) | – | – | – | 62 (11.55%) |
| Stage | |||||
| Stage I | 42 (7.18%) | 33 (13.20%) | 44 (15.17%) | – | 93 (17.32%) |
| Stage II | 270 (46.15%) | 76 (30.40%) | 93 (32.07%) | 73 (56.15%) | 209 (38.92%) |
| Stage III | 210 (35.90%) | 82 (32.80%) | 92 (31.72%) | 57 (43.85%) | 149 (27.75%) |
| Stage IV | 61 (10.43%) | 59 (23.60%) | 61 (21.03%) | – | 76 (14.15%) |
| Unknown | 2 (0.34%) | – | – | – | 10 (1.86%) |